1089280-36-3Relevant articles and documents
Anaplastic lymphoma kinase (ALK) inhibitor, and preparation method and application thereof
-
Paragraph 0167; 0168; 0169, (2018/07/30)
The invention relates to a compound as shown in a formula (I) which is described in the specification, and a pharmaceutical composition and a preparation method thereof. The compound can be used as anALK inhibitor for treatment of diseases mediated by ALK. The invention further relates to application of the compound as shown in the formula (I) and the pharmaceutical composition thereof to preparation of drugs used for treating diseases mediated by ALK.